Table 1 Tumor Characteristics, Molecular Analyses, and Clinical Outcome of 23 pN0 Patients (pN0 Group)
Case | Tumor site | T-stage | RT | Lymph nodes | Patient status | Follow-up (mo) | ||
|---|---|---|---|---|---|---|---|---|
No. analyzed | No. E48 positive | Level(s) involved | ||||||
1 | Tonsil | 2 | N | 10 | 0 | — | Alive | 48.5 |
2 | M Tongue | 2 | Y | 7 | 0 | — | Alive | 50 |
3 | Tonsil | 3 | Y | 12 | 2 | I | DOD | 28 |
4 | Larynx | 3 | Y | 10 | 0 | — | Alive | 46.5 |
5 | Inf Alv Process | 4 | N | 10 | 0 | — | Alive | 48 |
6 | Inf Alv Process | 4 | N | 12 | 0 | — | Alive | 43 |
7 | FOM | 1 | N | 10 | 0 | — | Alive | 41.5 |
8 | Inf Alv Process | 3 | Y | 10 | 0 | — | Alive | 44 |
9 | Tonsil | 3 | Y | 10 | 0 | — | Alive | 46 |
10 | Tonsil | 3 | Y | 14 | 1 | III | DOD | 14 |
11 | Inf Alv Process | 2 | N | 10 | 0 | — | DOC | 19 |
12 | Oropharynx | 2 | N | 10 | 0 | — | Alive | 41 |
13 | Inf Alv Process | 4 | Y | 10 | 0 | Alive | 39 | |
14 | M Tongue | 2 | N | 10 | 0 | — | Alive | 34 |
15 | Inf Alv Process | 4 | Y | 8 | 0 | — | Alive | 9 |
16 | Tonsil | 3 | Y | 10 | 0 | — | DOC | 21 |
17 | FOM | 4 | Y | 15 | 0 | — | Alive | 32.5 |
18 | B Tongue | 2 | Y | 10 | 0 | — | Alive | 31 |
19 | M Tongue | 3 | Y | 10 | 1 | III | Alive | 24 |
20 | FOM | 2 | N | 14 | 1 | II | Alive | 23 |
21 | Inf Alv Process | 4 | Y | 9 | 0 | — | Alive | 19 |
22 | Inf Alv Process | 4 | Y | 10 | 1 | III | Alive | 20 |
23 | Buccal Mucosa | 4 | Y | 10 | 0 | — | Alive | 20 |
